We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis Continues Clinical Trials Despite Patient Death
Novartis Continues Clinical Trials Despite Patient Death
June 5, 2008
Novartis will continue Phase III clinical trials of a multiple sclerosis (MS) drug despite two patient infections, including one fatality.